-
1
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
COI: 1:CAS:528:DC%2BD2MXit1Wksbk%3D, PID: 15758009
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330
-
(2005)
N Engl J Med
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
2
-
-
84872387620
-
The efficacy of temozolomide for recurrent glioblastoma multiforme
-
COI: 1:CAS:528:DC%2BC3sXhtVWhtb%2FI, PID: 22680781
-
Chen C, Xu T, Lu Y, Chen J, Wu S (2013) The efficacy of temozolomide for recurrent glioblastoma multiforme. Eur J Neurol 20(2):223–230. doi:10.1111/j.1468-1331.2012.03778.x
-
(2013)
Eur J Neurol
, vol.20
, Issue.2
, pp. 223-230
-
-
Chen, C.1
Xu, T.2
Lu, Y.3
Chen, J.4
Wu, S.5
-
3
-
-
77951648272
-
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study
-
COI: 1:CAS:528:DC%2BC3cXmtlSksrk%3D, PID: 20308655
-
Perry JR, Bélanger K, Mason WP, Fulton D, Kavan P, Easaw J, Shields C, Kirby S, Macdonald DR, Eisenstat DD, Thiessen B, Forsyth P, Pouliot J-F (2010) Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. J Clin Oncol 28(12):2051–2057. doi:10.1200/JCO.2009.26.5520
-
(2010)
J Clin Oncol
, vol.28
, Issue.12
, pp. 2051-2057
-
-
Perry, J.R.1
Bélanger, K.2
Mason, W.P.3
Fulton, D.4
Kavan, P.5
Easaw, J.6
Shields, C.7
Kirby, S.8
Macdonald, D.R.9
Eisenstat, D.D.10
Thiessen, B.11
Forsyth, P.12
Pouliot, J.-F.13
-
4
-
-
28044450847
-
Salvage temozolomide for prior temozolomide responders
-
COI: 1:CAS:528:DC%2BD2MXhtlWgt7bF, PID: 16270316
-
Franceschi E, Omuro AMP, Lassman AB, Demopoulos A, Nolan C, Abrey LE (2005) Salvage temozolomide for prior temozolomide responders. Cancer 104(11):2473–2476. doi:10.1002/cncr.21564
-
(2005)
Cancer
, vol.104
, Issue.11
, pp. 2473-2476
-
-
Franceschi, E.1
Omuro, A.M.P.2
Lassman, A.B.3
Demopoulos, A.4
Nolan, C.5
Abrey, L.E.6
-
5
-
-
67349125211
-
Rechallenge with temozolomide in patients with recurrent gliomas
-
COI: 1:CAS:528:DC%2BD1MXmtVKmsro%3D, PID: 19240962
-
Wick A, Pascher C, Wick W, Jauch T, Weller M, Bogdahn U, Hau P (2009) Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 256(5):734–741. doi:10.1007/s00415-009-5006-9
-
(2009)
J Neurol
, vol.256
, Issue.5
, pp. 734-741
-
-
Wick, A.1
Pascher, C.2
Wick, W.3
Jauch, T.4
Weller, M.5
Bogdahn, U.6
Hau, P.7
-
6
-
-
78349252105
-
Overview of cellular immunotherapy for patients with glioblastoma
-
Vauleon E, Avril T, Collet B, Mosser J, Quillien V (2010) Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol 2010:1–18. doi:10.1155/2010/689171
-
(2010)
Clin Dev Immunol
, vol.2010
, pp. 1-18
-
-
Vauleon, E.1
Avril, T.2
Collet, B.3
Mosser, J.4
Quillien, V.5
-
7
-
-
84863270634
-
Cellular-based immunotherapies for patients with glioblastoma multiforme
-
PID: 22474481
-
Xu X, Stockhammer F, Schmitt M (2012) Cellular-based immunotherapies for patients with glioblastoma multiforme. Clin Dev Immunol 2012:764213. doi:10.1155/2012/764213
-
(2012)
Clin Dev Immunol
, vol.2012
, pp. 764213
-
-
Xu, X.1
Stockhammer, F.2
Schmitt, M.3
-
8
-
-
4143103624
-
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
-
COI: 1:CAS:528:DC%2BD2cXmvFSlt74%3D, PID: 15328167
-
Wheeler CJ, Das A, Liu G, Yu JS, Black KL (2004) Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin Cancer Res 10(16):5316–5326. doi:10.1158/1078-0432.CCR-04-0497
-
(2004)
Clin Cancer Res
, vol.10
, Issue.16
, pp. 5316-5326
-
-
Wheeler, C.J.1
Das, A.2
Liu, G.3
Yu, J.S.4
Black, K.L.5
-
9
-
-
48149096721
-
Combined modality immunotherapy and chemotherapy: a new perspective
-
COI: 1:CAS:528:DC%2BD1cXovFyisbc%3D, PID: 18488219
-
Ramakrishnan R, Antonia S, Gabrilovich DI (2008) Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunol Immunother 57(10):1523–1529. doi:10.1007/s00262-008-0531-4
-
(2008)
Cancer Immunol Immunother
, vol.57
, Issue.10
, pp. 1523-1529
-
-
Ramakrishnan, R.1
Antonia, S.2
Gabrilovich, D.I.3
-
10
-
-
24744452216
-
IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide
-
COI: 1:CAS:528:DC%2BD2MXpslaitL0%3D, PID: 16140920
-
Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J (2005) IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65(17):7573–7579. doi:10.1158/0008-5472.CAN-05-0036
-
(2005)
Cancer Res
, vol.65
, Issue.17
, pp. 7573-7579
-
-
Natsume, A.1
Ishii, D.2
Wakabayashi, T.3
Tsuno, T.4
Hatano, H.5
Mizuno, M.6
Yoshida, J.7
-
11
-
-
77952203844
-
Activated CD4 + T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo
-
COI: 1:CAS:528:DC%2BD1MXhtlKhtr3O, PID: 19846868
-
Radfar S, Wang Y, Khong HT (2009) Activated CD4 + T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo. J Immunol 183(10):6800–6807. doi:10.4049/jimmunol.0901747
-
(2009)
J Immunol
, vol.183
, Issue.10
, pp. 6800-6807
-
-
Radfar, S.1
Wang, Y.2
Khong, H.T.3
-
12
-
-
0038167151
-
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma
-
COI: 1:CAS:528:DC%2BD3sXmt1Onu7Y%3D, PID: 12843792
-
Liu G, Khong HT, Wheeler CJ, Yu JS, Black KL, Ying H (2003) Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma. J Immunother 26(4):301–312
-
(2003)
J Immunother
, vol.26
, Issue.4
, pp. 301-312
-
-
Liu, G.1
Khong, H.T.2
Wheeler, C.J.3
Yu, J.S.4
Black, K.L.5
Ying, H.6
-
13
-
-
0030956966
-
Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas
-
COI: 1:CAS:528:DyaK2sXktFaksrk%3D, PID: 9176405
-
Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Morton DL, Hoon DS (1997) Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 150(6):2143–2152
-
(1997)
Am J Pathol
, vol.150
, Issue.6
, pp. 2143-2152
-
-
Chi, D.D.1
Merchant, R.E.2
Rand, R.3
Conrad, A.J.4
Garrison, D.5
Turner, R.6
Morton, D.L.7
Hoon, D.S.8
-
14
-
-
0034688176
-
Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications
-
COI: 1:CAS:528:DC%2BD3cXpvVSntQ%3D%3D, PID: 10656687
-
Chu W, Pak BJ, Bani MR, Kapoor M, Lu SJ, Tamir A, Kerbel RS, Ben-David Y (2000) Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications. Oncogene 19(3):395–402. doi:10.1038/sj.onc.1203315
-
(2000)
Oncogene
, vol.19
, Issue.3
, pp. 395-402
-
-
Chu, W.1
Pak, B.J.2
Bani, M.R.3
Kapoor, M.4
Lu, S.J.5
Tamir, A.6
Kerbel, R.S.7
Ben-David, Y.8
-
15
-
-
0035691971
-
Lineage-specific mechanism of drug and radiation resistance in melanoma mediated by tyrosinase-related protein 2
-
COI: 1:CAS:528:DC%2BD38XhsVWltbY%3D, PID: 11831643
-
Pak BJ, Chu W, Lu SJ, Kerbel RS, Ben-David Y (2001) Lineage-specific mechanism of drug and radiation resistance in melanoma mediated by tyrosinase-related protein 2. Cancer Metastasis Rev 20(1–2):27–32
-
(2001)
Cancer Metastasis Rev
, vol.20
, Issue.1-2
, pp. 27-32
-
-
Pak, B.J.1
Chu, W.2
Lu, S.J.3
Kerbel, R.S.4
Ben-David, Y.5
-
16
-
-
0032697226
-
Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis
-
COI: 1:CAS:528:DyaK1MXntlaktLc%3D, PID: 10596909
-
Nishioka E, Funasaka Y, Kondoh H, Chakraborty AK, Mishima Y, Ichihashi M (1999) Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis. Melanoma Res 9(5):433–443
-
(1999)
Melanoma Res
, vol.9
, Issue.5
, pp. 433-443
-
-
Nishioka, E.1
Funasaka, Y.2
Kondoh, H.3
Chakraborty, A.K.4
Mishima, Y.5
Ichihashi, M.6
-
17
-
-
21344462768
-
Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy
-
COI: 1:CAS:528:DC%2BD2MXmvFemsb4%3D, PID: 15897911
-
Liu G, Akasaki Y, Khong HT, Wheeler CJ, Das A, Black KL, Yu JS (2005) Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy. Oncogene 24(33):5226–5234. doi:10.1038/sj.onc.1208519
-
(2005)
Oncogene
, vol.24
, Issue.33
, pp. 5226-5234
-
-
Liu, G.1
Akasaki, Y.2
Khong, H.T.3
Wheeler, C.J.4
Das, A.5
Black, K.L.6
Yu, J.S.7
-
18
-
-
0037083317
-
Quantitatively determined survivin expression levels are of prognostic value in human gliomas
-
COI: 1:CAS:528:DC%2BD38XitFOqurw%3D, PID: 11844831
-
Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS (2002) Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20(4):1063–1068
-
(2002)
J Clin Oncol
, vol.20
, Issue.4
, pp. 1063-1068
-
-
Chakravarti, A.1
Noll, E.2
Black, P.M.3
Finkelstein, D.F.4
Finkelstein, D.M.5
Dyson, N.J.6
Loeffler, J.S.7
-
19
-
-
21344462864
-
No prognostic impact of survivin expression in glioblastoma
-
COI: 1:CAS:528:DC%2BD2MXltFGqt7g%3D, PID: 15843906
-
Preusser M, Gelpi E, Matej R, Marosi C, Dieckmann K, Rössler K, Budka H, Hainfellner JA (2005) No prognostic impact of survivin expression in glioblastoma. Acta Neuropathol 109(5):534–538. doi:10.1007/s00401-005-0992-x
-
(2005)
Acta Neuropathol
, vol.109
, Issue.5
, pp. 534-538
-
-
Preusser, M.1
Gelpi, E.2
Matej, R.3
Marosi, C.4
Dieckmann, K.5
Rössler, K.6
Budka, H.7
Hainfellner, J.A.8
-
20
-
-
77953216472
-
Antitumor cytotoxic T-cell response induced by a survivin peptide mimic
-
COI: 1:CAS:528:DC%2BC3cXmsFyktbY%3D, PID: 20422411
-
Ciesielski MJ, Ahluwalia MS, Munich SA, Orton M, Barone T, Chanan-Khan A, Fenstermaker RA (2010) Antitumor cytotoxic T-cell response induced by a survivin peptide mimic. Cancer Immunol Immunother 59(8):1211–1221. doi:10.1007/s00262-010-0845-x
-
(2010)
Cancer Immunol Immunother
, vol.59
, Issue.8
, pp. 1211-1221
-
-
Ciesielski, M.J.1
Ahluwalia, M.S.2
Munich, S.A.3
Orton, M.4
Barone, T.5
Chanan-Khan, A.6
Fenstermaker, R.A.7
-
21
-
-
69949120572
-
EGFRvIII-targeted vaccination therapy of malignant glioma
-
COI: 1:CAS:528:DC%2BD1MXht12htLzN, PID: 19744042
-
Choi BD, Archer GE, Mitchell DA, Heimberger AB, Mclendon RE, Bigner DD, Sampson JH (2009) EGFRvIII-targeted vaccination therapy of malignant glioma. Brain Pathol 19(4):713–723. doi:10.1111/j.1750-3639.2009.00318.x
-
(2009)
Brain Pathol
, vol.19
, Issue.4
, pp. 713-723
-
-
Choi, B.D.1
Archer, G.E.2
Mitchell, D.A.3
Heimberger, A.B.4
Mc lendon, R.E.5
Bigner, D.D.6
Sampson, J.H.7
-
22
-
-
0030603987
-
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
-
COI: 1:CAS:528:DyaK28XlsFWrtLg%3D, PID: 8841452
-
Romani N, Reider D, Heuer M, Ebner S, Kämpgen E, Eibl B, Niederwieser D, Schuler G (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196(2):137–151
-
(1996)
J Immunol Methods
, vol.196
, Issue.2
, pp. 137-151
-
-
Romani, N.1
Reider, D.2
Heuer, M.3
Ebner, S.4
Kämpgen, E.5
Eibl, B.6
Niederwieser, D.7
Schuler, G.8
-
23
-
-
0037943937
-
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
-
PID: 12682787
-
O’Rourke MGE, Johnson M, Lanagan C, See J, Yang J, Bell JR, Slater GJ, Kerr BM, Crowe B, Purdie DM, Elliott SL, Ellem KAO, Schmidt CW (2003) Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunol Immunother 52(6):387–395. doi:10.1007/s00262-003-0375-x
-
(2003)
Cancer Immunol Immunother
, vol.52
, Issue.6
, pp. 387-395
-
-
O’Rourke, M.G.E.1
Johnson, M.2
Lanagan, C.3
See, J.4
Yang, J.5
Bell, J.R.6
Slater, G.J.7
Kerr, B.M.8
Crowe, B.9
Purdie, D.M.10
Elliott, S.L.11
Ellem, K.A.O.12
Schmidt, C.W.13
-
24
-
-
31544437142
-
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas
-
PID: 16443946
-
Shah GD, Kesari S, Xu R, Batchelor TT, O’Neill AM, Hochberg FH, Levy B, Bradshaw J, Wen PY (2006) Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro-Oncology 8(1):38–46. doi:10.1215/S1522851705000529
-
(2006)
Neuro-Oncology
, vol.8
, Issue.1
, pp. 38-46
-
-
Shah, G.D.1
Kesari, S.2
Xu, R.3
Batchelor, T.T.4
O’Neill, A.M.5
Hochberg, F.H.6
Levy, B.7
Bradshaw, J.8
Wen, P.Y.9
-
25
-
-
0019365237
-
Reporting results of cancer treatment
-
COI: 1:STN:280:DyaL3M7htFOltw%3D%3D, PID: 7459811
-
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47(1):207–214
-
(1981)
Cancer
, vol.47
, Issue.1
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraten, B.2
Staquet, M.3
Winkler, A.4
-
26
-
-
3142760891
-
T cell immunity induced by live, necrotic, and apoptotic tumor cells
-
COI: 1:CAS:528:DC%2BD2cXlsVGjurc%3D, PID: 15240689
-
Bartholomae WC, Rininsland FH, Eisenberg JC, Boehm BO, Lehmann PV, Tary-Lehmann M (2004) T cell immunity induced by live, necrotic, and apoptotic tumor cells. J Immunol 173(2):1012–1022
-
(2004)
J Immunol
, vol.173
, Issue.2
, pp. 1012-1022
-
-
Bartholomae, W.C.1
Rininsland, F.H.2
Eisenberg, J.C.3
Boehm, B.O.4
Lehmann, P.V.5
Tary-Lehmann, M.6
-
27
-
-
33846955124
-
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
-
PID: 16944309
-
Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82(1):81–83. doi:10.1007/s11060-006-9241-y
-
(2007)
J Neurooncol
, vol.82
, Issue.1
, pp. 81-83
-
-
Chamberlain, M.C.1
Glantz, M.J.2
Chalmers, L.3
Van Horn, A.4
Sloan, A.E.5
-
28
-
-
84872705290
-
MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study
-
COI: 1:CAS:528:DC%2BC3sXktFCmug%3D%3D
-
Kimura T, McKolanis JR, Dzubinski LA, Islam K, Potter DM, Salazar AM, Schoen RE, Finn OJ (2013) MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) 6(1):18–26. doi:10.1158/1940-6207.CAPR-12-0275
-
(2013)
Cancer Prev Res (Phila)
, vol.6
, Issue.1
, pp. 18-26
-
-
Kimura, T.1
McKolanis, J.R.2
Dzubinski, L.A.3
Islam, K.4
Potter, D.M.5
Salazar, A.M.6
Schoen, R.E.7
Finn, O.J.8
-
29
-
-
84863096016
-
Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant
-
COI: 1:CAS:528:DC%2BC38XhtVSks7vP, PID: 22768182
-
Bauer M, Goldstein M, Heylmann D, Kaina B (2012) Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant. PLoS One 7(6):e39956. doi:10.1371/journal.pone.0039956
-
(2012)
PLoS One
, vol.7
, Issue.6
, pp. 39956
-
-
Bauer, M.1
Goldstein, M.2
Heylmann, D.3
Kaina, B.4
-
30
-
-
0033568012
-
Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta
-
COI: 1:CAS:528:DyaK1MXlvV2lt7s%3D, PID: 10477621
-
Schmidt M, Pauels HG, Lügering N, Lügering A, Domschke W, Kucharzik T (1999) Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J Immunol 163(6):3484–3490
-
(1999)
J Immunol
, vol.163
, Issue.6
, pp. 3484-3490
-
-
Schmidt, M.1
Pauels, H.G.2
Lügering, N.3
Lügering, A.4
Domschke, W.5
Kucharzik, T.6
-
31
-
-
33750088421
-
Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas
-
PID: 17038955
-
Ogden AT, Horgan D, Waziri A, Anderson D, Louca J, Mckhann GM, Sisti MB, Parsa AT, Bruce JN (2006) Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery 59(4):902–910. doi:10.1227/01.NEU.0000233907.03070.7B
-
(2006)
Neurosurgery
, vol.59
, Issue.4
, pp. 902-910
-
-
Ogden, A.T.1
Horgan, D.2
Waziri, A.3
Anderson, D.4
Louca, J.5
Mc khann, G.M.6
Sisti, M.B.7
Parsa, A.T.8
Bruce, J.N.9
-
32
-
-
0027294649
-
Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials
-
PID: 8478956
-
Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85(9):704–710
-
(1993)
J Natl Cancer Inst
, vol.85
, Issue.9
, pp. 704-710
-
-
Curran, W.J.1
Scott, C.B.2
Horton, J.3
Nelson, J.S.4
Weinstein, A.S.5
Fischbach, A.J.6
Chang, C.H.7
Rotman, M.8
Asbell, S.O.9
Krisch, R.E.10
-
33
-
-
80052738137
-
Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of radiation therapy oncology group-recursive partitioning analysis in the IMRT and temozolomide era
-
PID: 21181233
-
Paravati AJ, Heron DE, Landsittel D, Flickinger JC, Mintz A, Chen Y-F, Huq MS (2011) Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of radiation therapy oncology group-recursive partitioning analysis in the IMRT and temozolomide era. J Neurooncol 104(1):339–349. doi:10.1007/s11060-010-0499-8
-
(2011)
J Neurooncol
, vol.104
, Issue.1
, pp. 339-349
-
-
Paravati, A.J.1
Heron, D.E.2
Landsittel, D.3
Flickinger, J.C.4
Mintz, A.5
Chen, Y.-F.6
Huq, M.S.7
-
34
-
-
84870982871
-
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
-
PID: 22565485
-
De Vleeschouwer S, Ardon H, Van Calenbergh F, Sciot R, Wilms G, Van Loon J, Goffin J, Van Gool S (2012) Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination. Cancer Immunol Immunother 61(11):2105–2112. doi:10.1007/s00262-012-1271-z
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.11
, pp. 2105-2112
-
-
De Vleeschouwer, S.1
Ardon, H.2
Van Calenbergh, F.3
Sciot, R.4
Wilms, G.5
Van Loon, J.6
Goffin, J.7
Van Gool, S.8
-
35
-
-
23044479028
-
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
-
COI: 1:CAS:528:DC%2BD2MXmvFSmur0%3D, PID: 16061868
-
Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin J-W, Chute DJ, Mischel PS, Cloughesy TF, Roth MD (2005) Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res 11(15):5515–5525. doi:10.1158/1078-0432.CCR-05-0464
-
(2005)
Clin Cancer Res
, vol.11
, Issue.15
, pp. 5515-5525
-
-
Liau, L.M.1
Prins, R.M.2
Kiertscher, S.M.3
Odesa, S.K.4
Kremen, T.J.5
Giovannone, A.J.6
Lin, J.-W.7
Chute, D.J.8
Mischel, P.S.9
Cloughesy, T.F.10
Roth, M.D.11
-
36
-
-
79955784386
-
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
-
COI: 1:CAS:528:DC%2BC3MXktl2ls7c%3D, PID: 21149254
-
Sampson JH, Aldape KD, Archer GE, Coan A, Desjardins A, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, Mclendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling R, Shi W, Vredenburgh JJ, Bigner DD, Heimberger AB (2011) Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. Neuro-Oncology 13(3):324–333. doi:10.1093/neuonc/noq157
-
(2011)
Neuro-Oncology
, vol.13
, Issue.3
, pp. 324-333
-
-
Sampson, J.H.1
Aldape, K.D.2
Archer, G.E.3
Coan, A.4
Desjardins, A.5
Friedman, A.H.6
Friedman, H.S.7
Gilbert, M.R.8
Herndon, J.E.9
Mc lendon, R.E.10
Mitchell, D.A.11
Reardon, D.A.12
Sawaya, R.13
Schmittling, R.14
Shi, W.15
Vredenburgh, J.J.16
Bigner, D.D.17
Heimberger, A.B.18
-
37
-
-
35948930300
-
Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
-
COI: 1:CAS:528:DC%2BD2sXhsVersbrJ, PID: 17645496
-
Kim C-H, Woo S-J, Park J-S, Kim H-S, Park M-Y, Park S-D, Hong Y-K, Kim T-G (2007) Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma. Immunology 122(4):615–622. doi:10.1111/j.1365-2567.2007.02680.x
-
(2007)
Immunology
, vol.122
, Issue.4
, pp. 615-622
-
-
Kim, C.-H.1
Woo, S.-J.2
Park, J.-S.3
Kim, H.-S.4
Park, M.-Y.5
Park, S.-D.6
Hong, Y.-K.7
Kim, T.-G.8
-
38
-
-
59849125142
-
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity
-
COI: 1:CAS:528:DC%2BD1MXisVeqsbo%3D, PID: 18948646
-
Gangemi RMR, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27(1):40–48. doi:10.1634/stemcells.2008-0493
-
(2009)
Stem Cells
, vol.27
, Issue.1
, pp. 40-48
-
-
Gangemi, R.M.R.1
Griffero, F.2
Marubbi, D.3
Perera, M.4
Capra, M.C.5
Malatesta, P.6
Ravetti, G.L.7
Zona, G.L.8
Daga, A.9
Corte, G.10
-
39
-
-
83355166283
-
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
-
COI: 1:CAS:528:DC%2BC3MXhsF2lt7%2FP, PID: 22098779
-
Yang Y-P, Chien Y, Chiou G-Y, Cherng J-Y, Wang M-L, Lo W-L, Chang Y-L, Huang P-I, Chen Y-W, Shih Y-H, Chen M-T, Chiou S-H (2012) Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 33(5):1462–1476. doi:10.1016/j.biomaterials.2011.10.071
-
(2012)
Biomaterials
, vol.33
, Issue.5
, pp. 1462-1476
-
-
Yang, Y.-P.1
Chien, Y.2
Chiou, G.-Y.3
Cherng, J.-Y.4
Wang, M.-L.5
Lo, W.-L.6
Chang, Y.-L.7
Huang, P.-I.8
Chen, Y.-W.9
Shih, Y.-H.10
Chen, M.-T.11
Chiou, S.-H.12
-
40
-
-
84870985481
-
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
-
COI: 1:CAS:528:DC%2BC38Xhs1GlsbjN, PID: 22527250
-
Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh F, Menten J, Clement P, Debiec-Rychter M, De Vleeschouwer S (2012) Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial. Cancer Immunol Immunother 61(11):2033–2044. doi:10.1007/s00262-012-1261-1
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.11
, pp. 2033-2044
-
-
Ardon, H.1
Van Gool, S.W.2
Verschuere, T.3
Maes, W.4
Fieuws, S.5
Sciot, R.6
Wilms, G.7
Demaerel, P.8
Goffin, J.9
Van Calenbergh, F.10
Menten, J.11
Clement, P.12
Debiec-Rychter, M.13
De Vleeschouwer, S.14
-
41
-
-
84873989551
-
Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
-
COI: 1:CAS:528:DC%2BC3sXitlCis7c%3D, PID: 23377664
-
Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM (2013) Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother 36(2):152–157. doi:10.1097/CJI.0b013e3182811ae4
-
(2013)
J Immunother
, vol.36
, Issue.2
, pp. 152-157
-
-
Prins, R.M.1
Wang, X.2
Soto, H.3
Young, E.4
Lisiero, D.N.5
Fong, B.6
Everson, R.7
Yong, W.H.8
Lai, A.9
Li, G.10
Cloughesy, T.F.11
Liau, L.M.12
-
42
-
-
84872498982
-
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
-
PID: 22847020
-
Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuño MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, Yu JS (2012) Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother. doi:10.1007/s00262-012-1319-0
-
(2012)
Cancer Immunol Immunother
-
-
Phuphanich, S.1
Wheeler, C.J.2
Rudnick, J.D.3
Mazer, M.4
Wang, H.5
Nuño, M.A.6
Richardson, J.E.7
Fan, X.8
Ji, J.9
Chu, R.M.10
Bender, J.G.11
Hawkins, E.S.12
Patil, C.G.13
Black, K.L.14
Yu, J.S.15
-
43
-
-
84877355954
-
Dendritic cell immunotherapy
-
COI: 1:CAS:528:DC%2BC3sXpsFCntrk%3D, PID: 23651191
-
Sabado RL, Bhardwaj N (2013) Dendritic cell immunotherapy. Ann N Y Acad Sci 1284:31–45. doi:10.1111/nyas.12125
-
(2013)
Ann N Y Acad Sci
, vol.1284
, pp. 31-45
-
-
Sabado, R.L.1
Bhardwaj, N.2
|